Assessment of Breathing Pattern During NIV

Last updated: May 7, 2025
Sponsor: Fisher and Paykel Healthcare
Overall Status: Active - Recruiting

Phase

N/A

Condition

Copd (Chronic Obstructive Pulmonary Disease)

Treatment

NIV mask B

NIV mask A

Clinical Study ID

NCT06682286
U1111-1308-1838
  • Ages > 18
  • All Genders

Study Summary

COPD and OHS are respiratory conditions that disrupt normal breathing. Positive airway pressure, specifically Non-Invasive Ventilation (NIV), has been shown to improve breathing and reduce symptoms in patients with these conditions. Regular use of NIV can lead to better symptom management, improved quality of life, and reduced use of healthcare resources. The type of mask used for breathing support can greatly affect a patient's comfort and willingness to use it. For conditions like Obstructive Sleep Apnea (OSA), which is a physical blockage of the airway caused by the relaxation of the muscles of the throat, nasal masks are often used because they are comfortable and work well. But for breathing support in the hospital, full face masks are typically used because patients are having significant trouble breathing and tend to breathe through their mouth.

However, it's important to note that we don't yet fully understand the best way to provide breathing support for long-term NIV users, like COPD and OHS patients. The understanding of breathing route is currently only established for OSA. However, conditions like COPD affect the lungs and the overall system used for breathing, which is different from the throat blockage seen in OSA. So, the assumptions we make based on conditions like OSA may not apply to these other conditions. More research is needed to understand this better.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age over 18 years

  • Prescribed nocturnal NIV for COPD or OHS

  • Able to complete an overnight sleep study

  • Comfortable to sleep on a standard double bed

  • Capacity to complete informed consent

Exclusion

Exclusion Criteria:

  • Uncontrolled sleep apnea (Apnea-hypopnea index (AHI) over 15 events/hour offpersonal NIV device data)

  • Prescribed IPAP above 25 cmH2O

  • Self-reported pregnancy

  • Allergic to adhesive of the sensors

  • Self-reported cold/flu symptoms

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: NIV mask B
Phase:
Study Start date:
January 24, 2025
Estimated Completion Date:
September 30, 2025

Study Description

  • Participants undergo PSG, lying on their backs while their breathing route is recorded for about 30 minutes.

  • The participants are then put on their prescribed airway pressure support with the first randomized mask, and their breathing is recorded again for 30 minutes.

  • The mask is switched to the second mask, and the same procedure is repeated.

Participants are then moved to the sleep laboratory for the night where they are provided with beds.

  • They continue NIV therapy with the last mask used during the awake test.

  • After at least 60 minutes of recording, participants are awakened to switch back to the first mask. They are then allowed to sleep uninterrupted for the rest of the night.

Connect with a study center

  • Fisher and Paykel Healthcare Sleep Laboratory

    Auckland, 2013
    New Zealand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.